Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(22%)
Results Posted
33%(1 trials)

Phase Distribution

Ph phase_4
4
44%
Ph phase_1
1
11%
Ph not_applicable
2
22%
Ph phase_2
1
11%

Phase Distribution

1

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
1(12.5%)
Phase 2Efficacy & side effects
1(12.5%)
Phase 4Post-market surveillance
4(50.0%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(5)
Completed(3)
Other(1)

Detailed Status

Not yet recruiting3
Completed3
Recruiting1
unknown1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (12.5%)
Phase 21 (12.5%)
Phase 44 (50.0%)
N/A2 (25.0%)

Trials by Status

recruiting111%
unknown111%
active_not_recruiting111%
not_yet_recruiting333%
completed333%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9